{"id":"https://openalex.org/W2153096480","doi":"https://doi.org/10.1126/scitranslmed.3005747","title":"mTORC1 Inhibition Is Required for Sensitivity to PI3K p110\u03b1 Inhibitors in PIK3CA -Mutant Breast Cancer","display_name":"mTORC1 Inhibition Is Required for Sensitivity to PI3K p110\u03b1 Inhibitors in PIK3CA -Mutant Breast Cancer","alternate_titles":[],"publication_year":2013,"publication_date":"2013-07-31","ids":{"openalex":"https://openalex.org/W2153096480","doi":"https://doi.org/10.1126/scitranslmed.3005747","mag":"2153096480","pmid":"https://pubmed.ncbi.nlm.nih.gov/23903756","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3935768"},"language":"en","primary_location":{"id":"doi:10.1126/scitranslmed.3005747","doi":"https://doi.org/10.1126/scitranslmed.3005747","is_oa":false,"landing_page_url":"https://doi.org/10.1126/scitranslmed.3005747","pdf_url":null,"source":{"id":"https://openalex.org/S24207032","display_name":"Science Translational Medicine","issn_l":"1946-6234","issn":["1946-6234","1946-6242"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315823","host_organization_name":"American Association for the Advancement of Science","host_organization_lineage":["https://openalex.org/P4310315823"],"host_organization_lineage_names":["American Association for the Advancement of Science"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science Translational Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2153096480"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/articles/PMC3935768","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028992290","display_name":"Moshe Elkabets","orcid":"https://orcid.org/0000-0003-3634-9098","observed_orcids":["https://orcid.org/0000-0003-3634-9098"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Moshe Elkabets","raw_affiliation_strings":["Human Oncology & Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA","Massachusetts General Hospital Cancer Center, CNY 149, 13th Street, Charlestown, MA 02129, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Human Oncology & Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, CNY 149, 13th Street, Charlestown, MA 02129, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086182006","display_name":"Sadhna Vora","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sadhna Vora","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, CNY 149, 13th Street, Charlestown, MA 02129, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, CNY 149, 13th Street, Charlestown, MA 02129, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087308492","display_name":"Dejan Juric","orcid":"https://orcid.org/0000-0003-2983-7704","observed_orcids":["https://orcid.org/0000-0003-2983-7704"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dejan Juric","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, CNY 149, 13th Street, Charlestown, MA 02129, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, CNY 149, 13th Street, Charlestown, MA 02129, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037931371","display_name":"Natasha Morse","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Natasha Morse","raw_affiliation_strings":["Human Oncology & Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Human Oncology & Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072389805","display_name":"Mari A. Mino-Kenudson","orcid":"https://orcid.org/0000-0002-9092-2265","observed_orcids":["https://orcid.org/0000-0002-9092-2265"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mari Mino-Kenudson","raw_affiliation_strings":["Department of Pathology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046490043","display_name":"Taru E. Muranen","orcid":"https://orcid.org/0000-0003-4158-9002","observed_orcids":["https://orcid.org/0000-0003-4158-9002"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Taru Muranen","raw_affiliation_strings":["Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077621150","display_name":"Jessica J. Tao","orcid":"https://orcid.org/0000-0002-6532-4466","observed_orcids":["https://orcid.org/0000-0002-6532-4466"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica Tao","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, CNY 149, 13th Street, Charlestown, MA 02129, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, CNY 149, 13th Street, Charlestown, MA 02129, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013097988","display_name":"Ana Bosch Campos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ana Bosch Campos","raw_affiliation_strings":["Human Oncology & Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Human Oncology & Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031165814","display_name":"Jordi Ahnert Rodon","orcid":"https://orcid.org/0000-0001-6467-3632","observed_orcids":["https://orcid.org/0000-0001-6467-3632"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jordi Rodon","raw_affiliation_strings":["Experimental Therapeutics Group, Vall d\u2019Hebron Institute of Oncology, Pg Vall d\u2019Hebron, 119-129, Barcelona 08035, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics Group, Vall d\u2019Hebron Institute of Oncology, Pg Vall d\u2019Hebron, 119-129, Barcelona 08035, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109602405","display_name":"Yasir H. Ibrahim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Yasir H. Ibrahim","raw_affiliation_strings":["Experimental Therapeutics Group, Vall d\u2019Hebron Institute of Oncology, Pg Vall d\u2019Hebron, 119-129, Barcelona 08035, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics Group, Vall d\u2019Hebron Institute of Oncology, Pg Vall d\u2019Hebron, 119-129, Barcelona 08035, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073423716","display_name":"Violeta Serra","orcid":"https://orcid.org/0000-0001-6620-1065","observed_orcids":["https://orcid.org/0000-0001-6620-1065"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Violeta Serra","raw_affiliation_strings":["Experimental Therapeutics Group, Vall d\u2019Hebron Institute of Oncology, Pg Vall d\u2019Hebron, 119-129, Barcelona 08035, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics Group, Vall d\u2019Hebron Institute of Oncology, Pg Vall d\u2019Hebron, 119-129, Barcelona 08035, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081318256","display_name":"Vanessa S. Rodrik-Outmezguine","orcid":"https://orcid.org/0009-0006-3219-1181","observed_orcids":["https://orcid.org/0009-0006-3219-1181","https://orcid.org/0000-0002-3024-4490"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vanessa Rodrik-Outmezguine","raw_affiliation_strings":["Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110031493","display_name":"Saswati Hazra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Saswati Hazra","raw_affiliation_strings":["Prometheus Therapeutics & Diagnostics, 9410 Carroll Park Drive, San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prometheus Therapeutics & Diagnostics, 9410 Carroll Park Drive, San Diego, CA 92121, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080135700","display_name":"Sharat Singh","orcid":"https://orcid.org/0000-0001-8707-4317","observed_orcids":["https://orcid.org/0000-0001-8707-4317"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sharat Singh","raw_affiliation_strings":["Prometheus Therapeutics & Diagnostics, 9410 Carroll Park Drive, San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prometheus Therapeutics & Diagnostics, 9410 Carroll Park Drive, San Diego, CA 92121, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120697982","display_name":"Phillip Kim","orcid":"https://orcid.org/0000-0002-8255-0086","observed_orcids":["https://orcid.org/0000-0002-8255-0086"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Phillip Kim","raw_affiliation_strings":["Prometheus Therapeutics & Diagnostics, 9410 Carroll Park Drive, San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prometheus Therapeutics & Diagnostics, 9410 Carroll Park Drive, San Diego, CA 92121, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033930240","display_name":"Cornelia Quadt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Cornelia Quadt","raw_affiliation_strings":["Novartis Pharma AG, Forum 1, Novartis Campus, CH-4056 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Forum 1, Novartis Campus, CH-4056 Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088061207","display_name":"Manway Liu","orcid":"https://orcid.org/0000-0002-0991-3741","observed_orcids":["https://orcid.org/0000-0002-0991-3741"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manway Liu","raw_affiliation_strings":["Oncology Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044141815","display_name":"Alan Huang","orcid":"https://orcid.org/0000-0001-5501-0212","observed_orcids":["https://orcid.org/0000-0001-5501-0212"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan Huang","raw_affiliation_strings":["Oncology Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060228803","display_name":"Neal X. Rosen","orcid":"https://orcid.org/0000-0002-8307-654X","observed_orcids":["https://orcid.org/0000-0002-8307-654X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neal Rosen","raw_affiliation_strings":["Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040093136","display_name":"Jeffrey A. Engelman","orcid":"https://orcid.org/0009-0004-0775-4523","observed_orcids":["https://orcid.org/0009-0004-0775-4523"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey A. Engelman","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, CNY 149, 13th Street, Charlestown, MA 02129, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, CNY 149, 13th Street, Charlestown, MA 02129, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002819777","display_name":"Maurizio Scaltriti","orcid":"https://orcid.org/0000-0002-5522-1447","observed_orcids":["https://orcid.org/0000-0002-5522-1447"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Maurizio Scaltriti","raw_affiliation_strings":["Human Oncology & Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Human Oncology & Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004300577","display_name":"Jose M Baselga","orcid":"https://orcid.org/0000-0003-1361-4063","observed_orcids":["https://orcid.org/0000-0003-1361-4063"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jos\u00e9 Baselga","raw_affiliation_strings":["Human Oncology & Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Human Oncology & Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5002819777","https://openalex.org/A5004300577"],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":null,"apc_paid":null,"fwci":10.5862,"has_fulltext":false,"cited_by_count":378,"citation_normalized_percentile":{"value":0.99234602,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"5","issue":"196","first_page":"196ra99","last_page":"196ra99"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mtorc1-inhibition","display_name":"mTORC1 inhibition","score":0.8980000019073486},{"id":"https://openalex.org/keywords/pik3ca-mutation","display_name":"PIK3CA mutation","score":0.8259999752044678},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9369999766349792},{"id":"https://openalex.org/keywords/alpelisib","display_name":"alpelisib","score":0.9879999756813049},{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":0.8420000076293945},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8669999837875366},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.8500000238418579},{"id":"https://openalex.org/keywords/insulin-like-growth-factor-i","display_name":"insulin-like growth factor I","score":0.9620000123977661},{"id":"https://openalex.org/keywords/neuregulin-1","display_name":"neuregulin-1","score":1.0},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7440000176429749},{"id":"https://openalex.org/keywords/mtor-signaling","display_name":"mTOR signaling","score":0.6259999871253967}],"concepts":[{"id":"https://openalex.org/C98490376","wikidata":"https://www.wikidata.org/wiki/Q14876060","display_name":"mTORC1","level":4,"score":0.929989218711853},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6939797401428223},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.6712073087692261},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.576290488243103},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48261842131614685},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.48230886459350586},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43474507331848145},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3507475256919861},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.30595123767852783},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27461177110671997},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12428387999534607},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10445412993431091}],"mesh":[{"descriptor_ui":"D000068338","descriptor_name":"Everolimus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000076222","descriptor_name":"Mechanistic Target of Rapamycin Complex 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000081082","descriptor_name":"Phosphoinositide-3 Kinase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007334","descriptor_name":"Insulin-Like Growth Factor I","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020890","descriptor_name":"Neuregulin-1","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D038601","descriptor_name":"Ribosomal Protein S6","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D046912","descriptor_name":"Multiprotein Complexes","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D046912","descriptor_name":"Multiprotein Complexes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058534","descriptor_name":"Class I Phosphatidylinositol 3-Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058570","descriptor_name":"TOR Serine-Threonine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D058570","descriptor_name":"TOR Serine-Threonine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1126/scitranslmed.3005747","doi":"https://doi.org/10.1126/scitranslmed.3005747","is_oa":false,"landing_page_url":"https://doi.org/10.1126/scitranslmed.3005747","pdf_url":null,"source":{"id":"https://openalex.org/S24207032","display_name":"Science Translational Medicine","issn_l":"1946-6234","issn":["1946-6234","1946-6242"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315823","host_organization_name":"American Association for the Advancement of Science","host_organization_lineage":["https://openalex.org/P4310315823"],"host_organization_lineage_names":["American Association for the Advancement of Science"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science Translational Medicine","raw_type":"journal-article"},{"id":"pmid:23903756","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23903756","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science translational medicine","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:2916716","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3935768","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3935768","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3935768/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Sci Transl Med","raw_type":"Text"},{"id":"pmh:oai:lup.lub.lu.se:c8bdf825-d4dd-4f89-b10b-db99e00a1ca6","doi":null,"is_oa":false,"landing_page_url":"https://lup.lub.lu.se/record/c8bdf825-d4dd-4f89-b10b-db99e00a1ca6","pdf_url":null,"source":{"id":"https://openalex.org/S4306400536","display_name":"Lund University Publications (Lund University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I187531555","host_organization_name":"Lund University","host_organization_lineage":["https://openalex.org/I187531555"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Science Translational Medicine; 5(196), pp 1-14 (2013)","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:2916716","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3935768","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1148943325","display_name":"Mechanisms of extracellular matrix mediated drug resistance","funder_award_id":"K99CA180221","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000903436","display_name":"Non-genomic resistance mechanisms in EGFR-mutant lung cancer","funder_award_id":"R01CA137008","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W88663011","https://openalex.org/W1968852924","https://openalex.org/W1977267072","https://openalex.org/W1980039397","https://openalex.org/W1998682097","https://openalex.org/W1999025555","https://openalex.org/W2000954296","https://openalex.org/W2009886463","https://openalex.org/W2012116166","https://openalex.org/W2019607817","https://openalex.org/W2026842712","https://openalex.org/W2029754521","https://openalex.org/W2036450767","https://openalex.org/W2055624262","https://openalex.org/W2059256620","https://openalex.org/W2065481080","https://openalex.org/W2070732456","https://openalex.org/W2070765493","https://openalex.org/W2070841378","https://openalex.org/W2077529224","https://openalex.org/W2084839831","https://openalex.org/W2087861588","https://openalex.org/W2095949683","https://openalex.org/W2099019742","https://openalex.org/W2109263914","https://openalex.org/W2111125738","https://openalex.org/W2111752734","https://openalex.org/W2113458582","https://openalex.org/W2118217667","https://openalex.org/W2127063807","https://openalex.org/W2129172946","https://openalex.org/W2129202918","https://openalex.org/W2130084494","https://openalex.org/W2133490025","https://openalex.org/W2137618229","https://openalex.org/W2138173746","https://openalex.org/W2141134269","https://openalex.org/W2141180093","https://openalex.org/W2145804860","https://openalex.org/W2158305336","https://openalex.org/W2161249280","https://openalex.org/W2165404212","https://openalex.org/W2167188058","https://openalex.org/W2168023789","https://openalex.org/W2171095731","https://openalex.org/W2220670435","https://openalex.org/W2261189152","https://openalex.org/W2273740586","https://openalex.org/W3025193256","https://openalex.org/W4245485594"],"related_works":["https://openalex.org/W2005485750","https://openalex.org/W2334089645","https://openalex.org/W3134079690","https://openalex.org/W4391260845","https://openalex.org/W2012346684","https://openalex.org/W2156918228","https://openalex.org/W2506550081","https://openalex.org/W2476893289"],"abstract_inverted_index":{"Activating":[0],"mutations":[1],"of":[2,35,62,95,139,154,180,194,202,209],"the":[3,65,137,140,146,199,207],"PIK3CA":[4],"gene":[5],"occur":[6],"frequently":[7],"in":[8,27,87,112,152,156,159],"breast":[9,42],"cancer,":[10],"and":[11,105,158,173,183,205],"inhibitors":[12,196],"that":[13,48,71,164,191],"are":[14,24],"specific":[15],"for":[16,33],"phosphatidylinositol":[17],"3-kinase":[18],"(PI3K)":[19],"p110\u03b1,":[20],"such":[21,167],"as":[22,168],"BYL719,":[23,104],"being":[25],"investigated":[26],"clinical":[28,200],"trials.":[29],"In":[30,121],"a":[31],"search":[32],"correlates":[34],"sensitivity":[36,49],"to":[37,50,74,103,109,145,186],"p110\u03b1":[38,132],"inhibition":[39,61],"among":[40],"PIK3CA-mutant":[41,122],"cancer":[43,69,123],"cell":[44,55,124],"lines,":[45],"we":[46,162],"observed":[47],"BYL719":[51,75,150],"(as":[52],"assessed":[53],"by":[54],"proliferation)":[56],"was":[57,84,98,107],"associated":[58,99],"with":[59,100,126,149],"full":[60],"signaling":[63,129],"through":[64],"TORC1":[66],"pathway.":[67],"Conversely,":[68],"cells":[70,147],"were":[72],"resistant":[73],"had":[76],"persistently":[77],"active":[78],"mTORC1":[79,96,106,128,142,195],"signaling,":[80],"although":[81],"Akt":[82],"phosphorylation":[83],"inhibited.":[85],"Similarly,":[86],"patients,":[88],"pS6":[89],"(residues":[90],"240/4)":[91],"expression":[92],"(a":[93],"marker":[94],"signaling)":[97],"tumor":[101],"response":[102],"found":[108,163],"be":[110],"reactivated":[111],"tumors":[113],"from":[114],"patients":[115],"whose":[116],"disease":[117],"progressed":[118],"after":[119],"treatment.":[120],"lines":[125],"persistent":[127],"despite":[130],"PI3K":[131],"blockade":[133],"(that":[134],"is,":[135],"resistance),":[136],"addition":[138],"allosteric":[141],"inhibitor":[143],"RAD001":[144],"along":[148],"resulted":[151],"reversal":[153],"resistance":[155,185],"vitro":[157],"vivo.":[160],"Finally,":[161],"growth":[165,170],"factors":[166],"insulin-like":[169],"factor":[171],"1":[172,175],"neuregulin":[174],"can":[176],"activate":[177],"mammalian":[178],"target":[179],"rapamycin":[181],"(mTOR)":[182],"mediate":[184],"BYL719.":[187],"Our":[188],"findings":[189],"suggest":[190],"simultaneous":[192],"administration":[193],"may":[197],"enhance":[198],"activity":[201],"p110\u03b1-targeted":[203],"drugs":[204],"delay":[206],"appearance":[208],"resistance.":[210]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2153096480","counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":15},{"year":2024,"cited_by_count":46},{"year":2023,"cited_by_count":19},{"year":2022,"cited_by_count":17},{"year":2021,"cited_by_count":37},{"year":2020,"cited_by_count":36},{"year":2019,"cited_by_count":36},{"year":2018,"cited_by_count":18},{"year":2017,"cited_by_count":31},{"year":2016,"cited_by_count":34},{"year":2015,"cited_by_count":39},{"year":2014,"cited_by_count":31},{"year":2013,"cited_by_count":7}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
